Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | RNA recognition motif domain containing protein | 0.0066 | 0.1409 | 0.8762 |
Chlamydia trachomatis | glutamine binding protein | 0.0049 | 0.0588 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0066 | 0.1409 | 0.2825 |
Toxoplasma gondii | ABC1 family protein | 0.0037 | 0 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0066 | 0.1409 | 0.2825 |
Onchocerca volvulus | Heterochromatin protein 1 homolog | 0.0042 | 0.0234 | 1 |
Loa Loa (eye worm) | heterochromatin protein 1 | 0.007 | 0.1608 | 1 |
Echinococcus multilocularis | nmda type glutamate receptor | 0.0159 | 0.6041 | 1 |
Echinococcus granulosus | glutamate receptor NMDA | 0.0091 | 0.2644 | 0.4377 |
Loa Loa (eye worm) | TAR-binding protein | 0.0066 | 0.1409 | 0.8762 |
Echinococcus granulosus | tar DNA binding protein | 0.0066 | 0.1409 | 0.2333 |
Echinococcus granulosus | chromobox protein 1 | 0.007 | 0.1608 | 0.2662 |
Echinococcus granulosus | nmda type glutamate receptor | 0.0159 | 0.6041 | 1 |
Mycobacterium ulcerans | glutamine-binding lipoprotein GlnH | 0.0049 | 0.0588 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0037 | 0 | 0.5 |
Echinococcus granulosus | Glutamate receptor ionotropic kainate 2 | 0.0047 | 0.0488 | 0.0808 |
Echinococcus multilocularis | nmda type glutamate receptor | 0.01 | 0.3133 | 0.5186 |
Schistosoma mansoni | glutamate receptor NMDA | 0.0138 | 0.4988 | 1 |
Trichomonas vaginalis | chromobox protein, putative | 0.007 | 0.1608 | 1 |
Echinococcus granulosus | nmda type glutamate receptor | 0.01 | 0.3133 | 0.5186 |
Loa Loa (eye worm) | RNA binding protein | 0.0066 | 0.1409 | 0.8762 |
Echinococcus granulosus | chromobox protein 1 | 0.007 | 0.1608 | 0.2662 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0037 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0039 | 0.0086 | 0.0535 |
Echinococcus multilocularis | glutamate receptor 2 | 0.0047 | 0.0488 | 0.0808 |
Trichomonas vaginalis | chromobox protein, putative | 0.007 | 0.1608 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0066 | 0.1409 | 0.2825 |
Echinococcus granulosus | Glutamate receptor ionotropic kainate 2 | 0.0047 | 0.0488 | 0.0808 |
Echinococcus multilocularis | Glutamate receptor, ionotropic kainate 2 | 0.0047 | 0.0488 | 0.0808 |
Echinococcus multilocularis | Glutamate receptor, ionotropic kainate 2 | 0.0047 | 0.0488 | 0.0808 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0039 | 0.0086 | 0.0535 |
Echinococcus granulosus | glutamate receptor ionotrophic AMPA 3 | 0.0047 | 0.0488 | 0.0808 |
Echinococcus multilocularis | Glutamate receptor, ionotropic kainate 3 | 0.0068 | 0.1542 | 0.2552 |
Onchocerca volvulus | Heterochromatin protein 1 homolog | 0.0039 | 0.0086 | 0.3686 |
Mycobacterium leprae | Probable lipase LipE | 0.0037 | 0 | 0.5 |
Echinococcus multilocularis | Glutamate receptor, ionotropic kainate 2 | 0.0047 | 0.0488 | 0.0808 |
Echinococcus multilocularis | chromobox protein 1 | 0.007 | 0.1608 | 0.2662 |
Echinococcus granulosus | Glutamate receptor ionotropic kainate 2 | 0.0047 | 0.0488 | 0.0808 |
Brugia malayi | TAR-binding protein | 0.0066 | 0.1409 | 0.8762 |
Schistosoma mansoni | chromobox protein | 0.007 | 0.1608 | 0.3224 |
Trichomonas vaginalis | chromobox protein, putative | 0.0042 | 0.0234 | 0.1452 |
Echinococcus multilocularis | tar DNA binding protein | 0.0066 | 0.1409 | 0.2333 |
Mycobacterium leprae | conserved hypothetical protein | 0.0037 | 0 | 0.5 |
Echinococcus granulosus | glutamate receptor 2 | 0.0047 | 0.0488 | 0.0808 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0066 | 0.1409 | 0.8762 |
Brugia malayi | Heterochromatin protein 1 | 0.007 | 0.1608 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0066 | 0.1409 | 0.2825 |
Schistosoma mansoni | chromobox protein | 0.007 | 0.1608 | 0.3224 |
Mycobacterium tuberculosis | Probable glutamine-binding lipoprotein GlnH (GLNBP) | 0.0049 | 0.0588 | 0.0588 |
Treponema pallidum | amino acid ABC transporter, periplasmic binding protein | 0.0049 | 0.0588 | 0.5 |
Plasmodium vivax | hypothetical protein, conserved | 0.0037 | 0 | 0.5 |
Echinococcus multilocularis | chromobox protein 1 | 0.007 | 0.1608 | 0.2662 |
Loa Loa (eye worm) | hypothetical protein | 0.0039 | 0.0086 | 0.0535 |
Brugia malayi | RNA binding protein | 0.0066 | 0.1409 | 0.8762 |
Treponema pallidum | amino acid ABC transporter, periplasmic binding protein (hisJ) | 0.0049 | 0.0588 | 0.5 |
Chlamydia trachomatis | arginine ABC transporter substrate-binding protein ArtJ | 0.0049 | 0.0588 | 0.5 |
Echinococcus multilocularis | glutamate receptor NMDA | 0.0091 | 0.2644 | 0.4377 |
Trichomonas vaginalis | chromobox protein, putative | 0.0042 | 0.0234 | 0.1452 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0037 | 0 | 0.5 |
Echinococcus multilocularis | glutamate receptor, ionotrophic, AMPA 3 | 0.0047 | 0.0488 | 0.0808 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0037 | 0 | 0.5 |
Brugia malayi | chromobox protein homolog 3 | 0.0039 | 0.0086 | 0.0535 |
Schistosoma mansoni | tar DNA-binding protein | 0.0066 | 0.1409 | 0.2825 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
ED50 (functional) | > 300 mg kg-1 | Antibacterial activity againist E. coli 120 infected NMRI mice after peroral administration | ChEMBL. | 6379179 |
ED50 (functional) | > 300 mg kg-1 | Antibacterial activity againist E. coli 120 infected NMRI mice after peroral administration | ChEMBL. | 6379179 |
MIC (functional) | > 50 ug ml-1 | Minimum inhibitory concentration of compound against Escherichia coli delta 120 | ChEMBL. | 6379179 |
MIC (functional) | > 50 ug ml-1 | Minimum inhibitory concentration of compound against Salmonella typhimurium delta 119 | ChEMBL. | 6379179 |
MIC (functional) | > 50 ug ml-1 | Minimum inhibitory concentration of compound against Escherichia coli delta 120 | ChEMBL. | 6379179 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.